ANCA-associated vasculitis and VEXAS syndrome: a comment on the article by Muratore et al
Related Posts
Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer
Bardia A, Pistilli B, Rugo H. Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer. J Clin Oncol. 2025 Mar 28:JCO2402833.[...]
Jung SY, Pellegrini M, Yu H. Biological Aging in Combination with Lifestyle Factors in the Blood-Based Methylome: A Biomarker for Colorectal Cancer Susceptibility in African[...]
Kermani TA, Warrington KJ. Interleukin-6 inhibition for Takayasu's arteritis: before or after tumour necrosis factor inhibitors? Clin Exp Rheumatol. 2025 Mar 25. doi: 10.55563/clinexprheumatol/2acgxz. Epub[...]